• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Platelet Transfusion Use in the United States

December 30, 2019

Although RBC transfusions have decreased over the past decade, the demand for platelet transfusions has increased.   In order to better understand platelet transfusions, researchers retrospectively analyzed electronic data from 2013 to 2016 from 12 US hospitals participating in the Recipient and Donor Epidemiology Study III (REDS-III). Excluding patients under 18 years of age, 163,719 platelet products were transfused to 28,843 inpatients and 2987 outpatients with a mean of 1.30 platelet products transfused per episode. Over 60% of all platelets transfused were apheresis-derived, and 93% were leukoreduced. Fifty-four percent of transfusions were ABO identical, and 16% were ABO minor mismatches with plasma incompatibility; and 46% of all platelets were transfused to patients with leukemia, myelodysplastic syndrome, or lymphoma. With regard to inpatients, 42% of patients had counts 20,000/µL or less before transfusion, and 28% had platelet counts in the range of 20,000-50,000/µL. For outpatients, the most common pretransfusion platelet count was between 10,000 and 20,000/µL. Further studies are needed to better understand the effects of major and minor platelet mismatches and the appropriate platelet count thresholds triggering transfusions for all types of patients.

Reference:

Gottschall J, Wu Y, Triulzi D, Kleinman S, et al. The epidemiology of platelet transfusions: an analysis of platelet use at 12 US hospitals. Transfusion 2019

Filed Under

  • News
  • Platelet Transfusion

Recommended

  • Drones Capable of Delivering Blood Products

  • WHO May Add Blood to Model List of Essential Medicines

  • Urgent Global Need of Blood Products

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley